Veracyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.

CEO

Marc A. Stapley

CEOMarc A. Stapley

Employees

824

Employees824

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2006

Founded2006

Employees

824

Employees824

VCYT Key Statistics

Market cap

2.44B

Market cap2.44B

Price-Earnings ratio

73.18

Price-Earnings ratio73.18

Dividend yield

—

Dividend yield—

Average volume

1.15M

Average volume1.15M

High today

$31.57

High today$31.57

Low today

$27.24

Low today$27.24

Open price

$30.12

Open price$30.12

Volume

2.12M

Volume2.12M

52 Week high

$47.32

52 Week high$47.32

52 Week low

$19.73

52 Week low$19.73

VCYT News

TipRanks 22h

Veracyte’s Strong Performance and Promising Growth Opportunities Justify Buy Rating

William Blair analyst Andrew Brackmann has maintained their bullish stance on VCYT stock, giving a Buy rating on May 5. Andrew Brackmann has given his Buy rati...

TipRanks 1d

Veracyte reports Q1 adjusted EPS 31c, consensus 20c

Reports Q1 revenue $114.5M, consensus $110.97M. “We started 2025 with the eleventh consecutive quarter of 20% or more testing volume growth, driven by strong De...

Analyst ratings

77%

of 13 ratings

Buy

76.9%

Hold

15.4%

Sell

7.7%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.